HNF4α and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy

Diabetes

Volumn 57, Issue 4, 2008, Pages 1069-1077

  Niehof, Monika ^a   Borlak, Jürgen ^a,b  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; DNA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; SMALL INTERFERING RNA; STREPTOZOCIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; HNF4A PROTEIN, RAT; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRANSIENT RECEPTOR POTENTIAL CHANNEL RELATED PROTEIN 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL-RELATED PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DNA SEQUENCE; GENE EXPRESSION; GENE IDENTIFICATION; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; HUMAN CHROMOSOME; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; MALE; MOLECULAR CLONING; MOLECULAR DYNAMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ZUCKER DIABETIC FATTY RAT; ADOLESCENT; ANIMAL; CHILD; GENE EXPRESSION REGULATION; GENETICS; ONSET AGE; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; ZUCKER RAT;

ADOLESCENT; AGE OF ONSET; ANIMALS; CELL LINE, TUMOR; CHILD; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; KIDNEY; LIVER; RATS; RATS, ZUCKER; TRPC CATION CHANNELS;

EID: 42449109471     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1065     Document Type: Article

References (39)

1. Li J, Ning G, Duncan SA: Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 14:464-474, 2000
2. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ: Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21:1393-1403, 2001
3. Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, Kaestner KH, Rossi JM, Zaret KS, Duncan SA: Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 34:292-296, 2003
4. Chiba H, Itoh T, Satohisa S, Sakai N, Noguchi H, Osanai M, Kojima T, Sawada N: Activation of p21(CIP1/WAF1) gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4alpha. Exp Cell Res 302:11-21, 2005
5. Sladek FM, Seidel SD: Hepatocyte nuclear factor 4alpha. In Nuclear Receptors and Disease. Burris T, McCabe ERB, Eds. London, Academic Press, 2001, p. 309-361
6. Schrem H, Klempnauer J, Borlak J: Liver-enriched transcription factors in liver function and development. Part I. The hepatocyte nuclear factor network and liver-specific gene expression. PharmacolRev 54:129-158, 2002
7. Wang H, Maechler P, Antinozzi PA, Hagenfeldt KA, Wollheim CB: Hepato-cyte nuclear factor 4alpha regulates the expression of pancreatic beta-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J Biol Chem 275:35953-35959, 2000
8. Ryffel GU: Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J Mol Endocrinol 27:11-29, 2001
9. Mohlke KL, Boehnke M: The role of HNF4A variants in the risk of type 2 diabetes. Curr Diab Rep 5:149-156, 2005
10. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
11. Hayden MR, Whaley-Connell A, Sowers JR: Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte. Am J Nephrol 25:553-569, 2005
12. Yamagishi S, Fukami K, Ueda S, Okuda S: Molecular mechanisms of diabetic nephropathy and its therapeutic intervention. Curr Drug Targets 8:952-959, 2007
13. Berger M, Monks D, Wanner C, Lindner TH: Diabetic nephropathy: an inherited disease or just a diabetic complication? Kidney Blood Press Res 26:143-154, 2003
14. Schafer S, Linz W, Bube A, Gerl M, Huber J, Kurzel GU, Bleich M, Schmidts HL, Busch AE, Rutten H: Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats. Cardiovasc Res 60:447-454, 2003
15. Gorski K, Carneiro M, Schibler U: Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767-776, 1986
16. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res 11:1475-1489, 1983
17. Niehof M, Borlak J: RSK4 and PAK5 are novel candidate genes in diabetic rat kidney and brain. Mol Pharmacol 67:604-611, 2005
18. Kel A, Niehof M, Matyes V, Zemlin R, Borlak J: Computational identification of functionally active DNA binding sites for HNF4a. Genome Biol 9:R36, 2008
19. Dhein S, Kabat A, Olbrich A, Rosen P, Schroder H, Mohr FW: Effect of chronic treatment with vitamin E on endothelial dysfunction in a type I in vivo diabetes mellitus model and in vitro. J Pharmacol Exp Ther 305:114-122, 2003
20. Borlak J, Thum T: Induction of nuclear transcription factors, cytochrome P450 monooxygenases, and glutathione S-transferase alpha gene expression in Aroclor 1254-treated rat hepatocyte cultures. Biochem Pharmacol 61:145-153, 2001
21. Bianchi R, Buyukakilli B, Brines M, Savino C, Cavaletti G, Oggioni N, Lauria G, Borgna M, Lombardi R, Cimen B, Comelekoglu U, Kanik A, Tataroglu C, Cerami A, Ghezzi P: Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad SciUSA 101:823-828, 2004
22. Gross ML, El Shakmak A, Szabo A, Koch A, Kuhlmann A, Munter K, Ritz E, Amann K: ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia 46:856-868, 2003
23. Beech DJ: TRPC1: store-operated channel and more. Pflugers Arch 451: 53-60, 2005
24. Zagranichnaya TK, Wu X, Villereal ML: Endogenous TRPC1, TRPC3, and TRPC7 proteins combine to form native store-operated channels in HEK-293 cells. J Biol Chem 280:29559-29569, 2005
25. Tsiokas L, Arnould T, Zhu C, Kim E, Walz G, Sukhatme VP: Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad SciUSA 96:3934-3939, 1999
26. Huang CL: The transient receptor potential superfamily of ion channels. J Am Soc Nephrol 15:1690-1699, 2004
27. 2+ influx channels by regulating plasma membrane localization of TRPC1. J Biol Chem 278:27208-27215, 2003
28. 2+ channel in renal microcirculation and glomeruli. Exp Biol Med (Maywood) 231:145-153, 2006
29. Goel M, Sinkins WG, Zuo CD, Estacion M, Schilling WP: Identification and localization of TRPC channels in the rat kidney. Am J Physiol Renal Physiol 290:F1241-F1252, 2006
30. Sours S, Du J, Chu S, Ding M, Zhou XJ, Ma R: Expression of canonical transient receptor potential (TRPC) proteins in human glomerular mesan-gial cells. Am J Physiol Renal Physiol 290:F1507-F1515, 2006
31. Du J, Sours-Brothers S, Coleman R, Ding M, Graham S, Kong DH, Ma R: Canonical transient receptor potential 1 channel is involved in contractile function of glomerular mesangial cells. J Am, Soc Nephrol 18:1437-1445, 2007
32. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC: Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes: Pima Diabetes Genes Group. Diabetes 47:821-830, 1998
33. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS: Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 47:1164-1169, 1998
34. Manzoli L, Martelli AM, Billi AM, Faenza I, Fiume R, Cocco L: Nuclear phospholipase C: involvement in signal transduction. Prog Lipid Res 44:185-206, 2005
35. Martelli AM, Fiume R, Faenza I, Tabellini G, Evangelista C, Bortul R, Follo MY, Fala F, Cocco L: Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction. Histol Histopathol 20:1251-1260, 2005
36. Schena FP, Gesualdo L: Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16 (Suppl. 1):S30-S33, 2005
37. Anderson PW, McGill JB, Tuttle KR: Protein kinase C beta inhibition: the promise for treatment of diabetic nephropathy. Curr Opin Nephrol Hypertens 16:397-402, 2007
38. Noh H, King GL: The role of protein kinase C activation in diabetic nephropathy. Kidney Int Suppl 106:S49-S53, 2007
39. Tappia PS, Asemu G, Aroutiounova N, Dhalla NS: Defective sarcolemmal phospholipase C signaling in diabetic cardiomyopathy. Mol Cell Biochem 261:193-199, 2004